A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets

The docking of small molecules into the binding site of a target protein is an important but difficult step in structure‐based drug design. The performance of a docking algorithm is usually evaluated by re‐docking ligands into their native binding sites. We have explored the cross‐docking of 18 HIV‐...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proteins, structure, function, and bioinformatics structure, function, and bioinformatics, 2004-02, Vol.54 (3), p.526-533
Hauptverfasser: Daeyaert, Frits, de Jonge, Marc, Heeres, Jan, Koymans, Luc, Lewi, Paul, Vinkers, Maarten H., Janssen, Paul A.J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 533
container_issue 3
container_start_page 526
container_title Proteins, structure, function, and bioinformatics
container_volume 54
creator Daeyaert, Frits
de Jonge, Marc
Heeres, Jan
Koymans, Luc
Lewi, Paul
Vinkers, Maarten H.
Janssen, Paul A.J.
description The docking of small molecules into the binding site of a target protein is an important but difficult step in structure‐based drug design. The performance of a docking algorithm is usually evaluated by re‐docking ligands into their native binding sites. We have explored the cross‐docking of 18 HIV‐NNRTIs (non‐nucleoside inhibitors of HIV reverse transcriptase) of which the ligand–protein structure has been determined: each of the 18 ligands was docked into each of the 18 binding sites. The docking algorithms studied are an energy‐based simulated annealing algorithm and a novel pharmacophore docking algorithm. It turns out that the energy‐based docking of the ligands into non‐native pockets is far less successful than the docking into their native pockets. The results can be improved by using explicit pharmacophore information, and by docking a ligand into a panel of protein structures and selecting the ligand–proteincombination with the lowest interaction energy as the final result. Proteins 2004;54:000–000. © 2003 Wiley‐Liss, Inc.
doi_str_mv 10.1002/prot.10599
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80127813</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80127813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3639-bfa0f64ba92eaf0e55a971d491f25b4e230ac4b1d07d0edbbcf2963361c0f5043</originalsourceid><addsrcrecordid>eNp9kM1O6zAQhS0Egl5gwwMgr0C6UmAc589LVLilUlUQlJ-d5Tg2NSRxsF1deHtSWmDHamak7xxpPoQOCJwQgPi0czb0W8rYBhoQYHkEhCabaABFkUc0LdId9Mf7ZwDIGM220Q5J8qTozwFanOFuLlwjpO3m1ilcWfli2ics6ifrTJg3WLQVNsFj0XW1kSIY2-JgcZgrLJ31PvqKWI1JgS_H99F0ejMbH3ts2iVmHC5NWy2RrkdV8HtoS4vaq_313EV3_y5mw8tocjUaD88mkaQZZVGpBegsKQWLldCg0lSwnFQJIzpOy0TFFIRMSlJBXoGqylLqmGWUZkSCTiGhu-ho1dsrel0oH3hjvFR1LVplF54XQOK8ILQH_67Az4-c0rxzphHunRPgS8l8KZl_Su7hw3XromxU9YOurfYAWQH_Ta3ef6ni1zdXs6_SaJUxPqi374xwLzzLaZ7yh-mIT27PHygMgT_SD6Oql0w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80127813</pqid></control><display><type>article</type><title>A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Daeyaert, Frits ; de Jonge, Marc ; Heeres, Jan ; Koymans, Luc ; Lewi, Paul ; Vinkers, Maarten H. ; Janssen, Paul A.J.</creator><creatorcontrib>Daeyaert, Frits ; de Jonge, Marc ; Heeres, Jan ; Koymans, Luc ; Lewi, Paul ; Vinkers, Maarten H. ; Janssen, Paul A.J.</creatorcontrib><description>The docking of small molecules into the binding site of a target protein is an important but difficult step in structure‐based drug design. The performance of a docking algorithm is usually evaluated by re‐docking ligands into their native binding sites. We have explored the cross‐docking of 18 HIV‐NNRTIs (non‐nucleoside inhibitors of HIV reverse transcriptase) of which the ligand–protein structure has been determined: each of the 18 ligands was docked into each of the 18 binding sites. The docking algorithms studied are an energy‐based simulated annealing algorithm and a novel pharmacophore docking algorithm. It turns out that the energy‐based docking of the ligands into non‐native pockets is far less successful than the docking into their native pockets. The results can be improved by using explicit pharmacophore information, and by docking a ligand into a panel of protein structures and selecting the ligand–proteincombination with the lowest interaction energy as the final result. Proteins 2004;54:000–000. © 2003 Wiley‐Liss, Inc.</description><identifier>ISSN: 0887-3585</identifier><identifier>EISSN: 1097-0134</identifier><identifier>DOI: 10.1002/prot.10599</identifier><identifier>PMID: 14748000</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Algorithms ; Anti-HIV Agents - chemistry ; Anti-HIV Agents - metabolism ; Anti-HIV Agents - pharmacology ; Binding Sites ; Computer Simulation ; Crystallography, X-Ray ; Drug Design ; HIV - drug effects ; HIV - enzymology ; HIV Reverse Transcriptase - antagonists &amp; inhibitors ; HIV Reverse Transcriptase - chemistry ; HIV Reverse Transcriptase - metabolism ; Hydrogen Bonding ; Ligands ; Models, Molecular ; Reverse Transcriptase Inhibitors - chemistry ; Reverse Transcriptase Inhibitors - metabolism ; Reverse Transcriptase Inhibitors - pharmacology ; Thermodynamics ; Time Factors</subject><ispartof>Proteins, structure, function, and bioinformatics, 2004-02, Vol.54 (3), p.526-533</ispartof><rights>Copyright © 2003 Wiley‐Liss, Inc.</rights><rights>Copyright 2003 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3639-bfa0f64ba92eaf0e55a971d491f25b4e230ac4b1d07d0edbbcf2963361c0f5043</citedby><cites>FETCH-LOGICAL-c3639-bfa0f64ba92eaf0e55a971d491f25b4e230ac4b1d07d0edbbcf2963361c0f5043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fprot.10599$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fprot.10599$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14748000$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Daeyaert, Frits</creatorcontrib><creatorcontrib>de Jonge, Marc</creatorcontrib><creatorcontrib>Heeres, Jan</creatorcontrib><creatorcontrib>Koymans, Luc</creatorcontrib><creatorcontrib>Lewi, Paul</creatorcontrib><creatorcontrib>Vinkers, Maarten H.</creatorcontrib><creatorcontrib>Janssen, Paul A.J.</creatorcontrib><title>A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets</title><title>Proteins, structure, function, and bioinformatics</title><addtitle>Proteins</addtitle><description>The docking of small molecules into the binding site of a target protein is an important but difficult step in structure‐based drug design. The performance of a docking algorithm is usually evaluated by re‐docking ligands into their native binding sites. We have explored the cross‐docking of 18 HIV‐NNRTIs (non‐nucleoside inhibitors of HIV reverse transcriptase) of which the ligand–protein structure has been determined: each of the 18 ligands was docked into each of the 18 binding sites. The docking algorithms studied are an energy‐based simulated annealing algorithm and a novel pharmacophore docking algorithm. It turns out that the energy‐based docking of the ligands into non‐native pockets is far less successful than the docking into their native pockets. The results can be improved by using explicit pharmacophore information, and by docking a ligand into a panel of protein structures and selecting the ligand–proteincombination with the lowest interaction energy as the final result. Proteins 2004;54:000–000. © 2003 Wiley‐Liss, Inc.</description><subject>Algorithms</subject><subject>Anti-HIV Agents - chemistry</subject><subject>Anti-HIV Agents - metabolism</subject><subject>Anti-HIV Agents - pharmacology</subject><subject>Binding Sites</subject><subject>Computer Simulation</subject><subject>Crystallography, X-Ray</subject><subject>Drug Design</subject><subject>HIV - drug effects</subject><subject>HIV - enzymology</subject><subject>HIV Reverse Transcriptase - antagonists &amp; inhibitors</subject><subject>HIV Reverse Transcriptase - chemistry</subject><subject>HIV Reverse Transcriptase - metabolism</subject><subject>Hydrogen Bonding</subject><subject>Ligands</subject><subject>Models, Molecular</subject><subject>Reverse Transcriptase Inhibitors - chemistry</subject><subject>Reverse Transcriptase Inhibitors - metabolism</subject><subject>Reverse Transcriptase Inhibitors - pharmacology</subject><subject>Thermodynamics</subject><subject>Time Factors</subject><issn>0887-3585</issn><issn>1097-0134</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1O6zAQhS0Egl5gwwMgr0C6UmAc589LVLilUlUQlJ-d5Tg2NSRxsF1deHtSWmDHamak7xxpPoQOCJwQgPi0czb0W8rYBhoQYHkEhCabaABFkUc0LdId9Mf7ZwDIGM220Q5J8qTozwFanOFuLlwjpO3m1ilcWfli2ics6ifrTJg3WLQVNsFj0XW1kSIY2-JgcZgrLJ31PvqKWI1JgS_H99F0ejMbH3ts2iVmHC5NWy2RrkdV8HtoS4vaq_313EV3_y5mw8tocjUaD88mkaQZZVGpBegsKQWLldCg0lSwnFQJIzpOy0TFFIRMSlJBXoGqylLqmGWUZkSCTiGhu-ho1dsrel0oH3hjvFR1LVplF54XQOK8ILQH_67Az4-c0rxzphHunRPgS8l8KZl_Su7hw3XromxU9YOurfYAWQH_Ta3ef6ni1zdXs6_SaJUxPqi374xwLzzLaZ7yh-mIT27PHygMgT_SD6Oql0w</recordid><startdate>20040215</startdate><enddate>20040215</enddate><creator>Daeyaert, Frits</creator><creator>de Jonge, Marc</creator><creator>Heeres, Jan</creator><creator>Koymans, Luc</creator><creator>Lewi, Paul</creator><creator>Vinkers, Maarten H.</creator><creator>Janssen, Paul A.J.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040215</creationdate><title>A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets</title><author>Daeyaert, Frits ; de Jonge, Marc ; Heeres, Jan ; Koymans, Luc ; Lewi, Paul ; Vinkers, Maarten H. ; Janssen, Paul A.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3639-bfa0f64ba92eaf0e55a971d491f25b4e230ac4b1d07d0edbbcf2963361c0f5043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Algorithms</topic><topic>Anti-HIV Agents - chemistry</topic><topic>Anti-HIV Agents - metabolism</topic><topic>Anti-HIV Agents - pharmacology</topic><topic>Binding Sites</topic><topic>Computer Simulation</topic><topic>Crystallography, X-Ray</topic><topic>Drug Design</topic><topic>HIV - drug effects</topic><topic>HIV - enzymology</topic><topic>HIV Reverse Transcriptase - antagonists &amp; inhibitors</topic><topic>HIV Reverse Transcriptase - chemistry</topic><topic>HIV Reverse Transcriptase - metabolism</topic><topic>Hydrogen Bonding</topic><topic>Ligands</topic><topic>Models, Molecular</topic><topic>Reverse Transcriptase Inhibitors - chemistry</topic><topic>Reverse Transcriptase Inhibitors - metabolism</topic><topic>Reverse Transcriptase Inhibitors - pharmacology</topic><topic>Thermodynamics</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Daeyaert, Frits</creatorcontrib><creatorcontrib>de Jonge, Marc</creatorcontrib><creatorcontrib>Heeres, Jan</creatorcontrib><creatorcontrib>Koymans, Luc</creatorcontrib><creatorcontrib>Lewi, Paul</creatorcontrib><creatorcontrib>Vinkers, Maarten H.</creatorcontrib><creatorcontrib>Janssen, Paul A.J.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Proteins, structure, function, and bioinformatics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Daeyaert, Frits</au><au>de Jonge, Marc</au><au>Heeres, Jan</au><au>Koymans, Luc</au><au>Lewi, Paul</au><au>Vinkers, Maarten H.</au><au>Janssen, Paul A.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets</atitle><jtitle>Proteins, structure, function, and bioinformatics</jtitle><addtitle>Proteins</addtitle><date>2004-02-15</date><risdate>2004</risdate><volume>54</volume><issue>3</issue><spage>526</spage><epage>533</epage><pages>526-533</pages><issn>0887-3585</issn><eissn>1097-0134</eissn><abstract>The docking of small molecules into the binding site of a target protein is an important but difficult step in structure‐based drug design. The performance of a docking algorithm is usually evaluated by re‐docking ligands into their native binding sites. We have explored the cross‐docking of 18 HIV‐NNRTIs (non‐nucleoside inhibitors of HIV reverse transcriptase) of which the ligand–protein structure has been determined: each of the 18 ligands was docked into each of the 18 binding sites. The docking algorithms studied are an energy‐based simulated annealing algorithm and a novel pharmacophore docking algorithm. It turns out that the energy‐based docking of the ligands into non‐native pockets is far less successful than the docking into their native pockets. The results can be improved by using explicit pharmacophore information, and by docking a ligand into a panel of protein structures and selecting the ligand–proteincombination with the lowest interaction energy as the final result. Proteins 2004;54:000–000. © 2003 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>14748000</pmid><doi>10.1002/prot.10599</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0887-3585
ispartof Proteins, structure, function, and bioinformatics, 2004-02, Vol.54 (3), p.526-533
issn 0887-3585
1097-0134
language eng
recordid cdi_proquest_miscellaneous_80127813
source MEDLINE; Access via Wiley Online Library
subjects Algorithms
Anti-HIV Agents - chemistry
Anti-HIV Agents - metabolism
Anti-HIV Agents - pharmacology
Binding Sites
Computer Simulation
Crystallography, X-Ray
Drug Design
HIV - drug effects
HIV - enzymology
HIV Reverse Transcriptase - antagonists & inhibitors
HIV Reverse Transcriptase - chemistry
HIV Reverse Transcriptase - metabolism
Hydrogen Bonding
Ligands
Models, Molecular
Reverse Transcriptase Inhibitors - chemistry
Reverse Transcriptase Inhibitors - metabolism
Reverse Transcriptase Inhibitors - pharmacology
Thermodynamics
Time Factors
title A pharmacophore docking algorithm and its application to the cross-docking of 18 HIV-NNRTI's in their binding pockets
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A22%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20pharmacophore%20docking%20algorithm%20and%20its%20application%20to%20the%20cross-docking%20of%2018%20HIV-NNRTI's%20in%20their%20binding%20pockets&rft.jtitle=Proteins,%20structure,%20function,%20and%20bioinformatics&rft.au=Daeyaert,%20Frits&rft.date=2004-02-15&rft.volume=54&rft.issue=3&rft.spage=526&rft.epage=533&rft.pages=526-533&rft.issn=0887-3585&rft.eissn=1097-0134&rft_id=info:doi/10.1002/prot.10599&rft_dat=%3Cproquest_cross%3E80127813%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80127813&rft_id=info:pmid/14748000&rfr_iscdi=true